Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
J Clin Endocrinol Metab
; 104(5): 1417-1428, 2019 05 01.
Article
in En
| MEDLINE
| ID: mdl-30256977
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Cell Differentiation
/
Protein Kinase Inhibitors
/
Thyroid Cancer, Papillary
/
Vemurafenib
/
Iodine Radioisotopes
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2019
Document type:
Article
Country of publication:
United States